famotidine

Generic: famotidine

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name famotidine
Generic Name famotidine
Labeler camber pharmaceuticals, inc.
Dosage Form POWDER, FOR SUSPENSION
Routes
ORAL
Active Ingredients

famotidine 40 mg/5mL

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-063
Product ID 31722-063_03961211-aab3-1a19-e063-6394a90a2268
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217330
Listing Expiration 2026-12-31
Marketing Start 2023-08-17

Pharmacologic Class

Established (EPC)
histamine-2 receptor antagonist [epc]
Mechanism of Action
histamine h2 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722063
Hyphenated Format 31722-063

Supplemental Identifiers

RxCUI
310274
UPC
0331722063319
UNII
5QZO15J2Z8
NUI
N0000000151 N0000175784

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name famotidine (source: ndc)
Generic Name famotidine (source: ndc)
Application Number ANDA217330 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 40 mg/5mL
source: ndc
Packaging
  • 50 mL in 1 BOTTLE (31722-063-31)
source: ndc

Packages (1)

31722-063-31 50 mL in 1 BOTTLE (31722-063-31)

Ingredients (1)

famotidine (40 mg/5mL)

Linked Drug Pages (1)

FAMOTIDINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "03961211-aab3-1a19-e063-6394a90a2268", "openfda": {"nui": ["N0000000151", "N0000175784"], "upc": ["0331722063319"], "unii": ["5QZO15J2Z8"], "rxcui": ["310274"], "spl_set_id": ["8e7f9c85-d165-47c7-8950-b22adcd6cece"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 BOTTLE (31722-063-31)", "package_ndc": "31722-063-31", "marketing_start_date": "20230817"}], "brand_name": "FAMOTIDINE", "product_id": "31722-063_03961211-aab3-1a19-e063-6394a90a2268", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "31722-063", "generic_name": "FAMOTIDINE", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FAMOTIDINE", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "40 mg/5mL"}], "application_number": "ANDA217330", "marketing_category": "ANDA", "marketing_start_date": "20230817", "listing_expiration_date": "20261231"}